-
EP2590937
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2590937
| EP2590937 - PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2015 Database last updated on 03.09.2024 | Most recent event Tooltip | 26.06.2015 | Application deemed to be withdrawn | published on 29.07.2015 [2015/31] | Applicant(s) | For all designated states The University Of Nottingham University Park Nottingham, Nottinghamshire NG7 2RD / GB | [2013/20] | Inventor(s) | 01 /
MISTRY, Shailesh Centre for Biomolecular Sciences The University of Nottingham University Park Nottingham Nottinghamshire NG7 2RD / GB | 02 /
DARAS, Etienne Centre for Biomolecular Sciences The University of Nottingham University Park Nottingham Nottinghamshire NG7 2RD / GB | 03 /
FROMONT, Christophe Centre for Biomolecular Sciences The University of Nottingham University Park Nottingham Nottinghamshire NG7 2RD / GB | 04 /
JADHAV, Gopal Centre for Biomolecular Sciences The University of Nottingham University Park Nottingham Nottinghamshire NG7 2RD / GB | 05 /
FISCHER, Peter Martin Centre for Biomolecular Sciences The University of Nottingham University Park Nottingham Nottinghamshire NG7 2RD / GB | 06 /
KELLAM, Barrie Centre for Biomolecular Sciences The University of Nottingham University Park Nottingham Nottinghamshire NG7 2RD / GB | 07 /
HILL, Stephen John Faculty of Medicine&Health Sciences The University of Nottingham Medical School Nottingham Nottinghamshire NG7 2UH / GB | 08 /
BAKER, Jillian Glenda Faculty of Medicine&Health Sciences The University of Nottingham Medical School Nottingham Nottinghamshire NG7 2UH / GB | [2013/20] | Representative(s) | Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB | [N/P] |
| Former [2013/20] | Allen, Philippa Margaret Appleyard Lees 15 Clare Road Halifax, HX1 2HY / GB | Application number, filing date | 10734545.6 | 05.07.2010 | WO2010GB51106 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012004549 | Date: | 12.01.2012 | Language: | EN | [2012/02] | Type: | A1 Application with search report | No.: | EP2590937 | Date: | 15.05.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.01.2012 takes the place of the publication of the European patent application. | [2013/20] | Search report(s) | International search report - published on: | EP | 12.01.2012 | Classification | IPC: | C07C275/40, C07C275/28, C07C235/34, C07C335/20, A61K31/16, A61K31/17, A61P9/04 | [2013/20] | CPC: |
C07C217/34 (EP,US);
C07C217/64 (US);
A61P9/04 (EP);
C07C213/08 (US);
C07C231/12 (US);
C07C233/40 (EP,US);
C07C233/65 (EP,US);
C07C233/78 (EP,US);
C07C235/34 (EP,US);
C07C235/50 (EP,US);
C07C235/60 (EP,US);
C07C237/04 (EP,US);
C07C237/34 (EP,US);
C07C269/06 (US);
C07C271/28 (EP,US);
C07C273/1854 (US);
C07C275/28 (EP,US);
C07C275/30 (EP,US);
C07C275/34 (EP,US);
C07C275/36 (US);
C07C275/40 (EP,US);
C07C275/42 (EP,US);
C07C303/40 (US);
C07C311/13 (EP,US);
C07C335/16 (EP,US);
C07C335/20 (US);
C07C43/23 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2013/20] | Title | German: | PHENOXYPROPANOLDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON HERZ- UND HERZ-KREISLAUF-ERKRANKUNGEN | [2013/20] | English: | PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES | [2013/20] | French: | NOUVEAUX COMPOSÉS ET TRAITEMENTS AMÉLIORÉS POUR MALADIE CARDIAQUE ET CARDIOVASCULAIRE | [2013/20] | Entry into regional phase | 30.01.2013 | National basic fee paid | 30.01.2013 | Designation fee(s) paid | 30.01.2013 | Examination fee paid | Examination procedure | 30.01.2013 | Examination requested [2013/20] | 27.11.2013 | Amendment by applicant (claims and/or description) | 11.12.2013 | Loss of particular rights, legal effect: Claims | 15.01.2014 | Despatch of communication of loss of particular rights: Claims {1} | 10.10.2014 | Despatch of a communication from the examining division (Time limit: M04) | 21.02.2015 | Application deemed to be withdrawn, date of legal effect [2015/31] | 18.03.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/31] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.10.2014 | Fees paid | Renewal fee | 15.05.2013 | Renewal fee patent year 03 | 15.05.2013 | Renewal fee patent year 04 | 24.07.2014 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 05.02.2013 | 03 M06 Fee paid on 15.05.2013 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]JPS57108047 ; | [XD]EP0052072 (SANDOZ AG [CH]) [XD] 1-16 * claim 1; pages 3-18, 46, 47; example 1 *; | [XD]GB2132611 (SANDOZ LTD) [XD] 1-16 * pages 1-7, 12,13; example *; | [X] - DATABASE WPI, 0, Derwent World Patents Index, vol. 1982, no. 21, Database accession no. 1982-41862E, XP002638419 & JPS57108047 A 19820705 (SANDOZ AG) [X] 1-16 * abstract * * claims * | [A] - KLEPZIG M ET AL, "CGP 17582 - a beta-1-selective beta blocker without negative inotropic effect?", HERZ, KREISLAUF, PFLAUM, MUENCHEN, DE, (19860101), vol. 18, no. 9, ISSN 0046-7324, pages 439 - 442, XP009147192 [A] 1-11,14-16 * abstract * | [A] - REZMANN-VITTI LINDA A ET AL, "Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta(1)-adrenergic receptor", J. MED.CHEM., (2006), vol. 49, pages 3467 - 3477, XP002638420 [A] 1-11,14-16 * Fig. I, compound 9; page 3469, left column * DOI: http://dx.doi.org/10.1021/JM050624L | by applicant | EP0052072 | US4363651 | GB2132611 | US4497813 | CH664559 | EP0400519 | US5135932 | WO9713744 | WO2008083054 | - BAKER, BR. J PHARMACOL, (2005), vol. 144, pages 317 - 22 | - J MED CHEM, (2006), vol. 49, no. 12, pages 3467 - 3477 | - B J CLIN PHARM, (1989), vol. 27, no. 5, pages 553 - 561 | - S.E.DENMARK; J. P. EDWARDS, JOC, (1991), vol. 56, pages 6974 - 6981 | - SHARPLESS, JOC, (1989), vol. 54, no. 6, pages 1295 - 1304 | - GARDINER; BENNETT, AM J PHYSIOL., (198810), vol. 255, pages H813 - 24 |